Edgewise Therapeutics Inc (EWTX) — Cash Flow Quality Index

Latest as of December 2025: -0.33x

Edgewise Therapeutics Inc (EWTX) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of $-38.59 Million is below net income of $117.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore EWTX operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.33x

Operating CF / Net Income

Operating Cash Flow

$-38.59 Million

USD

Net Income

$117.58 Million

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Edgewise Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Edgewise Therapeutics Inc. For live market cap and the full company financial profile, see Edgewise Therapeutics Inc (EWTX) market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.